Found 69 matching trials
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer PHASE4 The aim of this study was to evaluate the efficacy, safety and tolerability...
Show More Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Learn More & Join Trial
Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer. PHASE2 The aim of this study is to evaluate the efficacy and safety of TQB2102 com...
Show More Location
Henan cancer hospital
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Neoadjuvant Treatment of Breast Cancer N/A Observational investigation of participants who are given neoadjuvant treat...
Show More Location
National Institute of Oncolgy
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer PHASE1 This is a study to compare the similarity in Pharmacokinetics (PK) profile ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer PHASE2 This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer PHASE3 This study is a multicenter, randomized, open-label, parallel Phase III cli...
Show More Status
Active Not Recruiting
Location
Shengjing Hospital, China Medical University
Learn More & Join Trial
Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients PHASE1 Neoadjuvant treatment is an important treatment for early breast cancer pat...
Show More Location
Peking University People'S Hospital
Learn More & Join Trial
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer PHASE2 The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Show More Location
Skåne University Hospital
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial